Amneal Pharmaceuticals Inc (NASDAQ:AMRX) price on Thursday, July 03, rose 0.60% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.42.
A look at the stock’s price movement, the close in the last trading session was $8.37, moving within a range at $8.26 and $8.46. The beta value (5-Year monthly) was 1.055. Turning to its 52-week performance, $9.48 and $6.49 were the 52-week high and 52-week low respectively. Overall, AMRX moved 13.02% over the past month.
Amneal Pharmaceuticals Inc’s market cap currently stands at around $2.64 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-02.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AMRX is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AMRX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AMRX’s current price about 5.97% and 10.22% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 66.64, while 7-day volatility ratio is 2.75% and 3.19% in the 30-day chart. Further, Amneal Pharmaceuticals Inc (AMRX) has a beta value of 1.12. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $11 and high of $11. Looking at the price targets, the low is -30.64% off current price level while to achieve the yearly target high, price needs to move -30.64%. Nonetheless, investors will most likely welcome a -30.64% jump to $11 which is the analysts’ median price.
If we refocus on Amneal Pharmaceuticals Inc (NASDAQ:AMRX), historical trading data shows that trading volumes averaged 1.96 over the past 10 days and 1.94 million over the past 3 months. The company’s latest data on shares outstanding shows there are 313.38 million shares.
The 54.15% of Amneal Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 39.72% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.35 million on 2025-06-13, giving us a short ratio of 3.37. The data shows that as of 2025-06-13 short interest in Amneal Pharmaceuticals Inc (AMRX) stood at 266.00001 of shares outstanding, with shares short falling to 5.36 million registered in 2025-05-15. Current price change has pushed the stock 31.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AMRX stock continues to rise going into the next quarter.
